Reports for LORAZEPAM

Ingredient

LORAZEPAM

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM SUBLINGUAL 1MG TABLET Resolved 2023-02-28 2023-05-01 185682
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-06-30 2023-04-28 163918
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-12-08 2023-04-28 177523
TEVA-LORAZEPAM 1MG TABLET Resolved 2022-06-30 2023-04-28 163912
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2023-02-03 2023-04-17 183599
PMS-LORAZEPAM 0.5MG TABLET Resolved 2023-02-08 2023-03-21 183870
ATIVAN 2MG TABLET Resolved 2022-09-26 2022-10-04 170189
APO-LORAZEPAM 2MG TABLET Resolved 2022-04-01 2022-05-13 157698
ATIVAN 2MG TABLET Resolved 2021-11-30 2022-02-01 150219
LORAZEPAM INJECTION USP 4MG SOLUTION Resolved 2020-11-06 2022-01-25 127901

Showing 11 to 20 of 80

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM 1MG TABLET Discontinued 2017-06-06 2017-06-07 11980
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11983
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11986

Showing 11 to 13 of 13